True NorthHealth Labs Build
Peptide Answers

compound

BPC-157 (5mg Vial) Questions Answered

BPC-157 (pentadecapeptide) is widely studied preclinically for cytoprotection, angiogenesis, and tissue repair mechanisms.

Read full protocol Calculate dose Find supplies TNHL ebooks
Educational reference only. TNHL does not diagnose, prescribe, or replace care from a licensed professional. Confirm all dosing, contraindications, and product decisions with qualified guidance.
Direct answer

BPC-157 (5mg Vial)

Phase Dosage (mcg) Units (per injection) (mL) Weeks 1–2 200 mcg (1× daily) 12 units (0.12 mL) Weeks 3–6 250 mcg (1× daily) 15 units (0.15 mL) Weeks 7–8 (Optional) 300 mcg (1× daily) 18 units (0.18 mL) Why 3 mL?

Quickstart Highlights

BPC-157 (pentadecapeptide) is widely studied preclinically for cytoprotection, angiogenesis, and tissue repair mechanisms.

Standard / Gradual Approach (3 mL = 1.67 mg/mL)

Phase Dosage (mcg) Units (per injection) (mL) Weeks 1–2 200 mcg (1× daily) 12 units (0.12 mL) Weeks 3–6 250 mcg (1× daily) 15 units (0.15 mL) Weeks 7–8 (Optional) 300 mcg (1× daily) 18 units (0.18 mL) Why 3 mL?

Supplies Needed

Approximate quantities for common 4–8 week designs. Peptide Vials (BPC-157 5mg): • 6 wks Standard ≈ 2 vials (≈9.8 mg total) • 8 wks Standard ≈ 3 vials (≈14 mg) • 8 wks Advanced (2×/day) ≈ 6 vials (≈28 mg) Insulin Syringes: • 6 wks 1×/day ≈ 42 • 8 wks 1×/day...

Potential Research Observations & Considerations

Preclinical studies have reported improved healing markers in GI and musculoskeletal models; robust human safety/efficacy data are limited.